Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...

Pericarditis I: Introduction

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Myocarditis I: Introduction

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...

Pericarditis III: Medical Management

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Aspiration and Bronchoscopic Retrieval of Dental Objects: A Literature Review and Data Analysis of Reported Cases.

Journal of bronchology & interventional pulmonology·2026

Same author

Improving internal medicine resident proficiency in non-invasive positive pressure ventilation and oxygen modalities through simulation training.

Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR·2026

Same author

A Rare Case of Aggressive Non-Hodgkin's Lymphoma of the Muscle in a Young Male Presenting as Necrotizing Myofasciitis.

Cureus·2024

Same author

Multi-Organ Systems Involvement in COVID-19 is Associated With a Worse Prognosis.

Journal of acute medicine·2024

Same author

Pulmonologist Education of the Teach-to-Goal Inhaler Technique for Those With Asthma and COPD.

Respiratory care·2024

Same author

In-hospital outcomes of pulmonary hypertension in HIV patients: A population based cohort study.

International journal of cardiology·2024

Search research articles

Related Experiment Video

Updated: Oct 14, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

COVID-19 Suspected myopericarditis without pulmonary involvement.

Steven Mirabella¹, Oshin Bansode¹, Hyfaa Mashaal¹

¹Department of Internal Medicine, Nassau University Medical Center, 2201 Hempstead Turnpike, East Meadow, NY 11554, United States of America; Department of Internal Medicine, Division of Pulmonary and Critical Care, Nassau University Medical Center, East Meadow, New York, United States of America.

Heart & Lung : the Journal of Critical Care

|November 3, 2021

Summary

Myopericarditis, a rare heart inflammation, can occur after COVID-19 recovery, even without lung issues. Prompt treatment with aspirin and colchicine led to a patient's full recovery from this severe cardiac complication.

Keywords:

Acute coronary syndrome COVID-19 Cardiac Coronavirus Coronavirus infections Myocarditis Myocytes Patient discharge Pericardial effusion Pericardiocentesis Severe acute respiratory syndrome coronavirus 2

More Related Videos

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Related Experiment Videos

Last Updated: Oct 14, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Area of Science:

Cardiology
Infectious Diseases
Critical Care Medicine

Background:

Myopericarditis is a rare cardiac complication associated with COVID-19.
While often linked to pulmonary symptoms, COVID-19 can present with isolated cardiac involvement.

Observation:

A case report details a young African American man who developed myopericarditis post-COVID-19 infection.
The patient required intensive care unit (ICU) admission and vasopressor support due to the severity of his condition.

Findings:

Myopericarditis can be a life-threatening consequence of COVID-19, occurring even after viral clearance.
The severity of cardiac involvement does not consistently correlate with the extent of pulmonary disease in COVID-19 patients.

Implications:

This case highlights the potential for severe cardiac manifestations following COVID-19, emphasizing the need for cardiac monitoring.
Early diagnosis and treatment with anti-inflammatory agents like aspirin and colchicine may be crucial for managing COVID-19-associated myopericarditis.
Healthcare providers should consider myopericarditis in patients presenting with cardiac symptoms after COVID-19, irrespective of respiratory status.